Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.

Haematologica - 1 Aug 2008

Yamaguchi Motoko, Nakamura Naoya, Suzuki Ritsuro, Kagami Yoshitoyo, Okamoto Masataka, Ichinohasama Ryo, Yoshino Tadashi, Suzumiya Junji, Murase Takuhei, Miura Ikuo, Ohshima Koichi, Nishikori Momoko, Tamaru Jun-ichi, Taniwaki Masafumi, Hirano Masami, Morishima Yasuo, Ueda Ryuzo, Shiku Hiroshi, Nakamura Shigeo

Abstract excerpt

BACKGROUND: De novo CD5-positive diffuse large B-cell lymphoma (CD5(+) DLBCL) is clinicopathologically and genetically distinct from CD5-negative (CD5(-)) DLBCL and mantle cell lymphoma. The aim of this retrospective study was to clarify the histopathological spectrum and obtain new information on the therapeutic implications of CD5(+) DLBCL. DESIGN AND METHOD: From 1984 to 2002, 120 patients with CD5(+) DLBCL...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to B-Lymphocytes

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to CD5 Antigens

Share to Immunohistochemistry

Share to Immunophenotyping

Share to Lymphoma, Large B-Cell, Diffuse

Share to Proto-Oncogene Proteins c-bcl-2

Share to Survival Analysis

Source

Identifiers

PMID: 18556402
DOI: 10.3324/haematol.12810

Genes

BCL2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients.PMID 18556402Read ↗

De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients.Semantic proximity Read ↗

Diffuse large B-cell lymphoma.Semantic proximity Read ↗

De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.Semantic proximity Read ↗

Diffuse large B-cell lymphoma--more than a diffuse collection of large B cells: an entity in search of a meaningful classification.Semantic proximity Read ↗

Toward a New Molecular Taxonomy of Diffuse Large B-cell Lymphoma.Semantic proximity Read ↗

Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.Semantic proximity Read ↗

CD5-positive diffuse large B-cell lymphoma with an unusual phenotype: Cytoplasmic CD20 (+), surface CD20 (-).Semantic proximity Read ↗

Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell.Semantic proximity Read ↗

Molecular and immunological dissection of diffuse large B cell lymphoma: CD5+, and CD5- with CD10+ groups may constitute clinically relevant subtypes.Semantic proximity Read ↗

Canine Lymphoma, More Than a Morphological Diagnosis: What We Have Learned about Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

MYD88, CD79B, and CARD11 gene mutations in CD5-positive diffuse large B-cell lymphoma.Semantic proximity Read ↗

Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.